Back to Search
SNEHA KARKI, MD
MD
Internal Medicine Physician
NPI: 1932693116IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD474678(PA)
CMS Specialties
PrimaryHOSPITALIST
Education
OTHER
Class of 2013
Research & Publications (20)
1-Arylmethyl-2,3-dioxo-2,3-dihydroindole thiosemicarbazones as leads for developing cytotoxins and anticonvulsants.
PMID 18608748·J Enzyme Inhib Med Chem·2009
7-preclinical
Seroprevalence of HIV and hepatitis C co-infection among blood donors in Kathmandu Valley, Nepal.
PMID 19323036·Southeast Asian J Trop Med Public Health·2009
8-other
Trends in hepatitis B and hepatitis C seroprevalence among Nepalese blood donors.
PMID 18653982·Jpn J Infect Dis·2008
8-other
Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
PMID 17765549·Bioorg Med Chem·2007
7-preclinical
Powder X-ray diffraction as an emerging method to structurally characterize organic solids.
PMID 17629292·Org Lett·2007
8-other
Semiclassical statistical mechanics of two-dimensional hard-body fluids.
PMID 15638684·J Chem Phys·2005
8-other
Assessing aggregation of peptide conjugate of doxorubicin using quasi-elastic light scattering and 600 MHz NMR.
PMID 15129984·Int J Pharm·2004
8-other
PLAC-24 is a cytoplasmic dynein-binding protein that is recruited to sites of cell-cell contact.
PMID 12006665·Mol Biol Cell·2002
7-preclinical
Oxidation of HMG-CoA reductase inhibitors by tert-butoxyl and 1, 1-diphenyl-2-picrylhydrazyl radicals: model reactions for predicting oxidatively sensitive compounds during preformulation.
PMID 11042599·J Pharm Sci·2000
8-other
A dynactin subunit with a highly conserved cysteine-rich motif interacts directly with Arp1.
PMID 10671518·J Biol Chem·2000
7-preclinical
The impact of Fc engineering on an anti-CD19 antibody: increased Fcgamma receptor affinity enhances B-cell clearing in nonhuman primates.
PMID 19109559·Blood·2009
7-preclinical
The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
PMID 18498909·Clin Ther·2008
4-observational
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
PMID 18829563·Cancer Res·2008
7-preclinical
Histological pattern of ovarian tumors and their age distribution.
PMID 18828427·Nepal Med Coll J·2008
8-other
Diagnosis of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) by fine needle aspiration cytology.
PMID 18773449·Diagn Cytopathol·2008
5-case
Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells.
PMID 18723496·Mol Cancer Ther·2008
8-other
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
PMID 18691763·Mol Immunol·2008
8-other
From research to national expansion: 20 years' experience of community-based management of childhood pneumonia in Nepal.
PMID 18545735·Bull World Health Organ·2008
8-other
Longitudinal changes in zinc transport kinetics, metallothionein and zinc transporter expression in a blood-brain barrier model in response to a moderately excessive zinc environment.
PMID 18061429·J Nutr Biochem·2008
7-preclinical
A molecular immunology approach to antibody humanization and functional optimization.
PMID 17079018·Mol Immunol·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 255 W LANCASTER AVE
PAOLI, PA 19301 - Phone
- (484) 565-1510
Quick Facts
- NPI
- 1932693116
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile